Individualization of dose and fractionation of radiotherapy for head and neck cancers

P. Blanchard; J. Biau; J. Castelli; Y. Tao; P. Graff; F. Nguyen

doi:10.1016/j.canrad.2019.07.131

Individualization of dose and fractionation of radiotherapy for head and neck cancers

Titre traduit de la contribution: Personnalisation de la dose et du fractionnement de la radiothérapie des cancers de la tête et du cou

P. Blanchard, J. Biau, J. Castelli, Y. Tao, P. Graff, F. Nguyen

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

1 Citation (Scopus)

Résumé

Head and neck cancers comprise a variety of tumours depending on the sub-site, for which target volumes and the prescribed doses need to be individualized according to each patient's history and presentation. This article aims at describing the main factors involved in decision-making regarding dose and volume, as well as ongoing research. Contouring and treatment guidelines, use of altered fractionation, major prognostic factors, the role of Human papillomavirus and of functional imaging will be presented and discussed.

Titre traduit de la contribution	Personnalisation de la dose et du fractionnement de la radiothérapie des cancers de la tête et du cou
langue originale	Anglais
Pages (de - à)	784-788
Nombre de pages	5
journal	Cancer/Radiotherapie
Volume	23
Numéro de publication	6-7
Les DOIs	https://doi.org/10.1016/j.canrad.2019.07.131
état	Publié - 1 oct. 2019

Accès au document

10.1016/j.canrad.2019.07.131

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{b571334bc16741c28843ae4789f6ad0a,

title = "Individualization of dose and fractionation of radiotherapy for head and neck cancers",

abstract = "Head and neck cancers comprise a variety of tumours depending on the sub-site, for which target volumes and the prescribed doses need to be individualized according to each patient's history and presentation. This article aims at describing the main factors involved in decision-making regarding dose and volume, as well as ongoing research. Contouring and treatment guidelines, use of altered fractionation, major prognostic factors, the role of Human papillomavirus and of functional imaging will be presented and discussed.",

keywords = "Chemotherapy, Epstein–Barr virus, Fractionation, Head and neck cancer, Meta-analysis, Nasopharyngeal cancer, Radiotherapy",

author = "P. Blanchard and J. Biau and J. Castelli and Y. Tao and P. Graff and F. Nguyen",

note = "Publisher Copyright: {\textcopyright} 2019 Soci{\'e}t{\'e} fran{\c c}aise de radioth{\'e}rapie oncologique (SFRO)",

year = "2019",

month = oct,

day = "1",

doi = "10.1016/j.canrad.2019.07.131",

language = "English",

volume = "23",

pages = "784--788",

journal = "Cancer/Radiotherapie",

issn = "1278-3218",

number = "6-7",

}

TY - JOUR

T1 - Individualization of dose and fractionation of radiotherapy for head and neck cancers

AU - Blanchard, P.

AU - Biau, J.

AU - Castelli, J.

AU - Tao, Y.

AU - Graff, P.

AU - Nguyen, F.

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Head and neck cancers comprise a variety of tumours depending on the sub-site, for which target volumes and the prescribed doses need to be individualized according to each patient's history and presentation. This article aims at describing the main factors involved in decision-making regarding dose and volume, as well as ongoing research. Contouring and treatment guidelines, use of altered fractionation, major prognostic factors, the role of Human papillomavirus and of functional imaging will be presented and discussed.

AB - Head and neck cancers comprise a variety of tumours depending on the sub-site, for which target volumes and the prescribed doses need to be individualized according to each patient's history and presentation. This article aims at describing the main factors involved in decision-making regarding dose and volume, as well as ongoing research. Contouring and treatment guidelines, use of altered fractionation, major prognostic factors, the role of Human papillomavirus and of functional imaging will be presented and discussed.

KW - Chemotherapy

KW - Epstein–Barr virus

KW - Fractionation

KW - Head and neck cancer

KW - Meta-analysis

KW - Nasopharyngeal cancer

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85072545764&partnerID=8YFLogxK

U2 - 10.1016/j.canrad.2019.07.131

DO - 10.1016/j.canrad.2019.07.131

M3 - Article

C2 - 31420129

AN - SCOPUS:85072545764

SN - 1278-3218

VL - 23

SP - 784

EP - 788

JO - Cancer/Radiotherapie

JF - Cancer/Radiotherapie

IS - 6-7

ER -